March 5, 2026: FDA Issues Warning Letter to Novo Nordisk About Reporting Adverse Events for its GLP-1s The FDAs Center for Drug Evaluation and Research (CDER) has issued a warning letter to Novo Nordisk, Ozempics maker
Rushing escalation leads to more severe side effects at higher doses that could have been avoided with patience
Glutathione peroxidase mimics, synthetic compounds replicating the enzymes action, hold exciting potential for treating oxidative stress-related conditions
Residual age-related metabolic variability cannot be excluded and should be addressed in future studies using larger, age-stratified cohorts
Feldmans Breathwork Protocols, Post-Lunch (02:02:05) Deliberately Variable Breathwork: The Feldman Protocol (02:06:29) Magnesium Threonate & Cognition & Memory (02:18:27) Gratitude for Dr
GHK-Cu at 50 mg in 1 mL of bac water (50 mg/mL) sits at the high end of its solubility